INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
D000970:Antineoplastic Agents; D001859:Bone Neoplasms; D003609:Dactinomycin; D005260:Female; D005467:Floxuridine; D005472:Fluorouracil; D005833:Genital Neoplasms, Female; D006801:Humans; D066298:In Vitro Techniques; D007414:Intestinal Neoplasms; D007938:Leukemia; D008466:Mechlorethamine; D008545:Melanoma; D015122:Mercaptopurine; D008727:Methotrexate; D009369:Neoplasms / Q000628:therapy*; D010610:Pharyngeal Neoplasms; D012142:Respiratory Tract Neoplasms; D013274:Stomach Neoplasms; D013852:Thiotepa
D000970:Antineoplastic Agents; D005467:Floxuridine; D003609:Dactinomycin; D008466:Mechlorethamine; D013852:Thiotepa; D015122:Mercaptopurine; D005472:Fluorouracil; D008727:Methotrexate
ACTINOMYCIN; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; FLUORODEOXYURIDINE; FLUOROURACIL; GYNECOLOGIC NEOPLASMS; INTESTINAL NEOPLASMS; LEUKEMIA; MECHLORETHAMINE; MELANOMA; MERCAPTOPURINE; METHOTREXATE; NEOPLASM THERAPY; PHARYNGEAL NEOPLASMS; RESPIRATORY TRACT NEOPLASMS; STOMACH NEOPLASMS; THIO-TEPA